Canadian pharmaceutical company H&P Labs, Inc., announced earlier this month a partnership with Harvard and the Brigham and Women’s Hospital dedicated to the development of a new drug to fight the Ebola virus. James Cunningham, associate professor of medicine, is the project’s head researcher.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?